Product
Capoten
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
An Open-label, Randomized Three Period, Three Sequence, Partially Replicated Crossover Bioequivalence Study of Two Oral Formulations of Captopril 50 mg Film Coated Tablets in Healthy Adult Participants Under Fasting ConditionsStatus: Withdrawn, Estimated PCD: 2022-03-25